Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of CDK5R1 mRNA | affects expression | 16483693
|
D003913 |
Dextroamphetamine |
Dextroamphetamine results in increased cleavage of CDK5R1 protein | increases cleavage | 18991853
|
D003913 |
Dextroamphetamine |
Dextroamphetamine results in increased expression of CDK5R1 protein | increases expression | 18991853
|
C015001 |
arsenite |
arsenite metabolite results in increased cleavage of CDK5R1 protein | increases cleavage | 18242949
|
C015001 |
arsenite |
arsenite metabolite results in increased expression of CDK5R1 mRNA | increases expression | 18242949
|
C015001 |
arsenite |
arsenite metabolite results in increased expression of CDK5R1 protein | increases expression | 18242949
|
C015001 |
arsenite |
calpeptin inhibits the reaction [arsenite metabolite results in increased cleavage of CDK5R1 protein] | decreases reaction|increases cleavage | 18242949
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of CDK5R1 mRNA | increases expression | 19146932
|
D002118 |
Calcium |
Calcium results in increased cleavage of CDK5R1 protein | increases cleavage | 18242949
|
D002118 |
Calcium |
calpeptin inhibits the reaction [Calcium results in increased cleavage of CDK5R1 protein] | decreases reaction|increases cleavage | 18242949
|
C071482 |
calpeptin |
calpeptin inhibits the reaction [arsenite metabolite results in increased cleavage of CDK5R1 protein] | decreases reaction|increases cleavage | 18242949
|
C071482 |
calpeptin |
calpeptin inhibits the reaction [Calcium results in increased cleavage of CDK5R1 protein] | decreases reaction|increases cleavage | 18242949
|
D003024 |
Clozapine |
Clozapine results in increased expression of CDK5R1 mRNA | increases expression | 17266109
|
D004317 |
Doxorubicin |
Doxorubicin affects the expression of CDK5R1 mRNA | affects expression | 15205334
|
D005472 |
Fluorouracil |
Fluorouracil affects the expression of CDK5R1 mRNA | affects expression | 15205334
|
D017313 |
Fenretinide |
Fenretinide results in decreased expression of CDK5R1 mRNA | decreases expression | 16570282
|
D007657 |
Ketone Bodies |
Ketone Bodies results in decreased expression of CDK5R1 mRNA | decreases expression | 16807920
|
D008628 |
Mercury |
Mercury results in increased expression of CDK5R1 mRNA | increases expression | 16823088
|
D008770 |
Methylnitrosourea |
Methylnitrosourea results in increased cleavage of CDK5R1 protein | increases cleavage | 17069801
|
D010622 |
Phencyclidine |
Phencyclidine results in increased expression of CDK5R1 mRNA | increases expression | 17266109
|
D020849 |
Raloxifene |
[Raloxifene co-treated with ESR2 protein] results in decreased expression of CDK5R1 mRNA | affects cotreatment|decreases expression | 19059307
|
D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of CDK5R1 mRNA | increases expression | 16705456
|
D013629 |
Tamoxifen |
[Tamoxifen co-treated with ESR2 protein] results in decreased expression of CDK5R1 mRNA | affects cotreatment|decreases expression | 19059307
|
D024505 |
Tocopherols |
Tocopherols results in increased expression of CDK5R1 mRNA | increases expression | 17654050
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of CDK5R1 mRNA | increases expression | 17045167
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.49 | 14745880 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.50 | 18287403 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
13.42 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
13.42 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Fenretinide |
13.42 | 10697514 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
13.42 | 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Methylnitrosourea |
13.42 | 15688392 15113128 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.61 | 6695378 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
4.99 | 12649775 14617031 16160616 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
11.25 | 21441931 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
11.25 | 17451421 17308373 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.56 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.53 | 15800139 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
3.65 | 16511603 15504547 17963324 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.01 | 19183758 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.04 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.25 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.32 | 16456186 |
MESH:D001321 |
Autistic Disorder |
|
Mercury |
2.79 | 17497416 |
MESH:D001327 |
Autoimmune Diseases |
|
Mercury |
4.81 | 16634805 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.34 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
3.55 | 16197459 16206674 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.64 | 14601052 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.41 | 16580743 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
8.92 | 17150277 |
MESH:D001932 |
Brain Neoplasms |
|
Fenretinide |
8.92 | 16187019 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
4.69 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
4.69 | 15939500 18382427 16264153 11325840 15567936 15692762 17426702 17369602 18695136 15993339 19526202 17983394 16322301 18234424 16595493 16826403 15136595 15634643 15668708 16935488 18628466 16115903 16096432 15994142 |
MESH:D001943 |
Breast Neoplasms |
|
Fenretinide |
4.69 | 16601279 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
4.69 | 16557594 16595493 18357371 15136595 18608205 19217205 16110121 |
MESH:D001943 |
Breast Neoplasms |
|
Methylnitrosourea |
4.69 | 16253758 14633655 11306469 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
4.69 | 17595753 17440819 16912660 16837676 15572757 17049068 17261762 17242785 17952589 15775269 17893378 15758505 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
4.69 | 20135344 17261762 19084267 18815881 15668708 19200415 19142967 19189210 19155303 21152245 18629630 19288272 20544844 20390343 19011961 19115204 11161223 19189212 16273361 15565566 19103187 20859285 16202921 19221464 18821012 17893378 16873071 19066611 18855134 17049068 18984771 20005174 19244106 18425577 19410462 19059307 18997820 16818667 19487384 19289846 21138602 17440819 17242785 18351453 20065188 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
4.69 | 16443354 16166294 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.53 | 16813970 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
12.17 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
12.17 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
3.51 | 17121937 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.44 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.10 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
8.79 | 18059187 16234567 16023760 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fenretinide |
8.79 | 16270382 17159502 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
8.79 | 16332177 17088986 17045692 17971768 16799960 18930000 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
8.79 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
8.79 | 1917145 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
6.57 | 16201981 1485588 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
6.57 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
14.15 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
14.15 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fenretinide |
14.15 | 16274795 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
14.15 | 17066447 18986760 16757204 16280240 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
14.15 | 16051514 16096774 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
9.30 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
9.30 | 17572228 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.48 | 17351982 17007740 17974986 17382496 15792986 16612575 16952015 17519947 16651473 15476868 15811867 16455267 17928571 17924179 18627295 16242529 16278810 17308081 16731534 16364871 17329180 17131338 16269455 15505089 16109756 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
6.11 | 16243910 17334414 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Mercury |
6.11 | 10334427 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.40 | 15775269 |
MESH:D002386 |
Cataract |
|
Methylnitrosourea |
7.61 | 12484553 |
MESH:D002386 |
Cataract |
|
Tretinoin |
7.61 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitrosourea |
3.75 | 2727394 7505956 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Fenretinide |
12.77 | 16154183 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
12.77 | 16129372 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.10 | 16461808 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.69 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.64 | 9407595 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
11.47 | 17123785 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
11.47 | 15800139 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.64 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
3.92 | 15037631 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
3.92 | 16510598 17725105 16340194 18772588 17018589 15001691 17016597 17169374 17172411 17287894 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
3.56 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fenretinide |
3.56 | 17273769 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
3.56 | 18802399 17255274 16524972 14970324 18448328 16391804 17695437 17094418 20501625 17401013 17454858 18383874 15148649 18949393 17594712 17016601 15289873 16303861 18509181 18288408 16331619 16282729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
1.82 | 10589399 9211117 17551590 9142499 8800419 9224671 14991402 16925845 9664655 9125849 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.73 | 16733453 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.30 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.10 | 17474826 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Mercury |
3.73 | 16823706 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.72 | 16285004 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
2.96 | 16402076 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
8.84 | 17451421 17308373 15920148 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
8.84 | 19279558 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
5.50 | 15331141 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
4.08 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
4.08 | 15131321 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.62 | 18602426 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
4.13 | 16402076 |
MESH:D004487 |
Edema |
|
Raloxifene |
3.28 | 15860553 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.41 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
9.03 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
9.03 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
12.24 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
12.24 | 17893378 16202921 20544844 19155303 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
12.24 | 16569247 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.10 | 18037988 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.43 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
4.43 | 15173087 16337965 17638652 16481741 16785472 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.53 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
arsenite |
12.93 | 18296743 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
12.93 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
12.93 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.19 | 16709447 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.47 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
11.24 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
11.24 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Methylnitrosourea |
5.17 | 11555667 |
MESH:D005355 |
Fibrosis |
|
arsenite |
8.82 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
8.82 | 17994277 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
11.76 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Fenretinide |
11.76 | 16187019 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
11.76 | 17312396 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
6.29 | 16145905 |
MESH:D005910 |
Glioma |
|
Methylnitrosourea |
6.29 | 9825942 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
12.72 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
12.72 | 15162350 18337622 15102660 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
12.72 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.10 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.54 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.54 | 9664655 14991402 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
7.69 | 17875725 16144979 16879835 16244371 14766674 16330681 18006777 17888722 16244372 16707910 16495754 18674790 12587719 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
7.69 | 11110106 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.30 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.84 | 15692506 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.35 | 15147373 18501091 17606976 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.16 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.50 | 16778211 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
4.85 | 16046005 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
2.84 | 15787275 17577099 |
MESH:D007248 |
Infertility, Male |
|
Methylnitrosourea |
3.75 | 7193160 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
2.32 | 19457130 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.23 | 14714311 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.70 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
3.84 | 17551590 15992940 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
6.43 | 15699352 15369732 16775033 |
MESH:D007674 |
Kidney Diseases |
|
Mercury |
6.43 | 17934191 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.09 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
7.32 | 16985049 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
7.32 | 18625569 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
4.99 | 16316344 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.43 | 16973256 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.74 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.10 | 16085563 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.64 | 16482212 19285840 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.07 | 19850784 17596541 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.11 | 9834237 12679006 17361223 17649720 16823087 17506722 17294898 16788101 17107899 19029980 19075265 16140955 16891316 17339181 17712046 16935935 19225113 17301526 17217047 19642359 16766008 19035177 16331271 15748426 17368321 |
MESH:D007972 |
Leukoplakia, Oral |
|
Fenretinide |
5.99 | 16707609 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Methylnitrosourea |
8.30 | 15526292 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
8.30 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
7.92 | 17567588 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
7.92 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
3.38 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
3.53 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
3.53 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
3.53 | 16248980 18397230 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
7.32 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
7.32 | 18383874 17045692 16603448 15113037 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
7.32 | 16684651 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
2.97 | 17085340 16842330 |
MESH:D038061 |
Lower Extremity Deformities, Congenital |
|
Methylnitrosourea |
5.40 | 16080182 |
MESH:D008175 |
Lung Neoplasms |
|
arsenite |
8.47 | 16809336 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
8.47 | 20869020 20464547 20064080 18520028 18816296 17053015 18569708 6695378 20135361 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
8.47 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
8.47 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Methylnitrosourea |
8.47 | 18062963 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
8.47 | 18625569 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.73 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
7.78 | 16098063 |
MESH:D008223 |
Lymphoma |
|
Methylnitrosourea |
7.78 | 11418001 16257854 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Methylnitrosourea |
10.24 | 14633661 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
10.24 | 14737004 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.73 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.50 | 15621674 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.70 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
18.43 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Fenretinide |
18.43 | 10697514 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Methylnitrosourea |
18.43 | 15688392 10767621 14999141 15113128 12931682 11807958 16944150 14633655 10838139 16619500 11751437 17131329 16827153 16051031 15313902 19196723 17020996 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
18.43 | 14580682 19196723 11731420 16827153 19196722 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tocopherols |
18.43 | 17927505 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.49 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.76 | 17453147 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
7.25 | 16827129 |
MESH:D008545 |
Melanoma |
|
Fenretinide |
7.25 | 16270382 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
7.25 | 19393235 12393984 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
7.25 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.12 | 15990972 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.36 | 16940565 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
3.89 | 16856516 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
6.69 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Tocopherols |
6.69 | 15878867 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
4.35 | 19142101 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.44 | 15792986 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.50 | 15863610 |
MESH:D009041 |
Motion Sickness |
|
Dextroamphetamine |
5.47 | 1613127 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
14.16 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fenretinide |
14.16 | 16274795 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
14.16 | 16757204 18986760 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.73 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.39 | 16497877 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.04 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
2.92 | 15857846 19429709 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.50 | 16343187 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
5.78 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.78 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.49 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
15.42 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Fenretinide |
15.42 | 17353921 15958647 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
15.42 | 18600527 18239605 16928823 |
MESH:D009369 |
Neoplasms |
|
Methylnitrosourea |
15.42 | 15533788 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
15.42 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
Methylnitrosourea |
4.41 | 12696579 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.94 | 19189210 19200415 19196722 |
MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
4.35 | 15738583 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.70 | 16636307 16899518 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.94 | 16889571 15640375 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
3.71 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.01 | 9142499 |
MESH:D009442 |
Neurilemmoma |
|
Methylnitrosourea |
5.42 | 11555667 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.23 | 15555623 |
MESH:D009472 |
Neuronal Ceroid-Lipofuscinoses |
|
Fenretinide |
5.62 | 16303764 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.39 | 16436463 |
MESH:D009765 |
Obesity |
|
Clozapine |
3.00 | 18515891 19142110 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
7.39 | 17882678 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
7.39 | 15775268 17882678 19059307 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.16 | 17823083 15758505 17893378 15579764 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.06 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Fenretinide |
5.11 | 16133793 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
5.11 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.85 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fenretinide |
12.23 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
12.23 | 16500647 19003803 16929163 15113037 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Methylnitrosourea |
12.23 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
12.23 | 15976015 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.10 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.10 | 17638057 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.94 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.94 | 15897917 18437689 16868541 16729912 16888761 15749863 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fenretinide |
2.94 | 17024972 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.94 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
Methylnitrosourea |
2.94 | 15682402 12376480 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.94 | 16536755 16220300 15731164 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
2.94 | 18760546 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.94 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tocopherols |
2.94 | 12504091 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.54 | 16636307 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
4.13 | 15331141 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.73 | 16723453 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.50 | 15770314 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.95 | 18286688 15538739 16160472 18722050 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.16 | 17922066 |
MESH:D012162 |
Retinal Degeneration |
|
Fenretinide |
9.32 | 16303925 |
MESH:D012162 |
Retinal Degeneration |
|
Methylnitrosourea |
9.32 | 18155124 18172121 |
MESH:D012175 |
Retinoblastoma |
|
Methylnitrosourea |
5.42 | 11555667 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.04 | 16116481 16283617 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.93 | 17710206 16767912 15625365 17203757 18313854 15675481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.18 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.73 | 17846226 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
2.73 | 16141801 20107430 19369910 20580759 20452607 17726453 11151749 18855531 17123785 11763009 20168265 20521326 18806925 17667964 20521320 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
13.38 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
13.38 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Fenretinide |
13.38 | 16467112 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
13.38 | 16467112 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.50 | 15625365 17203757 16767912 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.24 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.98 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
4.71 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
4.71 | 17498489 15786421 17172411 19084572 18567086 18396642 16951190 17522103 19015929 16424979 |
MESH:D013274 |
Stomach Neoplasms |
|
Methylnitrosourea |
4.71 | 16257854 15930296 18593901 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
4.71 | 17261132 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.77 | 16837676 |
MESH:D013953 |
Thymus Neoplasms |
|
Methylnitrosourea |
5.17 | 11418001 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
11.84 | 16010429 17909728 |
MESH:D013964 |
Thyroid Neoplasms |
|
Methylnitrosourea |
11.84 | 7505956 3078959 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
11.84 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
5.15 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
9.63 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
9.63 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.19 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
15.56 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
15.56 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Fenretinide |
15.56 | 16720286 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
15.56 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
15.56 | 16712894 8653321 17572228 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fenretinide |
15.62 | 16154183 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
15.62 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
15.62 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.55 | 16752155 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.15 | 16837676 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.16 | 16364871 17638931 17334414 17678736 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.99 | 16761959 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.50 | 16343187 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
4.41 | 16402076 20107430 20521320 17502770 16141801 20564506 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
5.02 | 17933447 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.91 | 16287080 |